Arcus Capital Partners’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-20,000
Closed -$69K 109
2018
Q3
$69K Hold
20,000
0.03% 106
2018
Q2
$94K Hold
20,000
0.05% 103
2018
Q1
$63K Hold
20,000
0.04% 100
2017
Q4
$98K Hold
20,000
0.06% 110
2017
Q3
$137K Hold
20,000
0.07% 109
2017
Q2
$132K Hold
20,000
0.08% 101
2017
Q1
$160K Hold
20,000
0.1% 102
2016
Q4
$186K Hold
20,000
0.13% 96
2016
Q3
$212K Hold
20,000
0.15% 64
2016
Q2
$187K Hold
20,000
0.18% 60
2016
Q1
$208K Hold
20,000
0.15% 58
2015
Q4
$201K Buy
+20,000
New +$200K 0.14% 62

Other funds holding OPK

Arcus Capital Partners's OPK Position: Q4 2018 in Review

Arcus Capital Partners sold out of Opko Health (OPK) in Q4 2018, closing a stake of 20,000 shares — an estimated $69K sold.

Arcus Capital Partners first reported a position in OPK in Q4 2015 and held it in 12 quarters. The position peaked at $212K in Q3 2016. 202 funds tracked by Wall St. Rank hold OPK as of Q4 2018.

  • Arcus Capital Partners reported no remaining Opko Health position as of Q4 2018 after selling out during the quarter.
  • Arcus Capital Partners sold 20,000 Opko Health shares in Q4 2018, an estimated $69K.
  • Arcus Capital Partners first reported a position in Opko Health in Q4 2015 and held it in 12 quarters.
  • Arcus Capital Partners's Opko Health position peaked at $212K in Q3 2016.
  • 202 funds tracked by Wall St. Rank held Opko Health as of Q4 2018.

Based on Arcus Capital Partners's 13F filing for Q4 2018, filed 11 Feb 2019.